VHCP Management III’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

VHCP Management III’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$10.8M	Buy	1,254,041 +625,000	+99%	+$3.51M	2.15%	12
2019 Q3	$3.88M	Buy	629,041 +314,300	+100%	+$2.54M	2.39%	10
2019 Q2	$5.22M	Hold	314,741	–	–	2.44%	11
2019 Q1	$5.26M	Hold	314,741	–	–	3.07%	11
2018 Q4	$3.61M	Buy	314,741 +146,673	+87%	+$2.97M	2.63%	10
2018 Q3	$6.72M	Buy	+168,068	New	+$4.78M	5.08%	8

Other funds holding MRNS

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

VHCP Management III's MRNS Position: Q4 2019 in Review

VHCP Management III increased its Marinus Pharmaceuticals, Inc (MRNS) stake by 99% in Q4 2019, buying an estimated $3.51M and bringing the position to 1,254,041 shares worth $10.8M. The position accounts for 2.15% of the portfolio, ranked #12.

VHCP Management III first reported a position in MRNS in Q3 2018 and has held it in 6 quarters since. 79 funds tracked by Wall St. Rank hold MRNS as of Q4 2019.

VHCP Management III held 1,254,041 shares of Marinus Pharmaceuticals, Inc worth $10.8M as of Q4 2019.
VHCP Management III bought 625,000 Marinus Pharmaceuticals, Inc shares in Q4 2019, an estimated $3.51M.
Marinus Pharmaceuticals, Inc made up 2.15% of VHCP Management III's portfolio in Q4 2019, its #12 holding.
VHCP Management III first reported a position in Marinus Pharmaceuticals, Inc in Q3 2018 and has held it in 6 quarters since.
79 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.